Structure and Dynamics of Viral Substrate Recognition and Drug Resistance: A Dissertation

作者: Aysegul Ozen

DOI: 10.13028/M2JK5V

关键词: HIV Protease InhibitorNS3EnzymeViral structural proteinResistance mutationChemistryBiochemistryVirologyDrug resistanceViral entryProtease

摘要: Drug resistance is a major problem in quickly evolving diseases, including the human immunodeficiency (HIV) and hepatitis C viral (HCV) infections. The proteases (HIV protease HCV NS3/4A protease) are primary drug targets. At molecular level, reflects subtle change balance of recognition; resistant variants no longer effectively inhibited by competitive molecules but can process natural substrates with enough efficiency for survival. Therefore, inhibitors that better mimic substrate binding features should result more robust flat profiles. native adopt consensus volume when bound to enzyme, envelope. most severe mutations occur at residues contacted outside To guide design inhibitors, we investigate shared varied properties protein dynamics taken into account define dynamic envelope both proteases. compared detect structural basis mutation patterns. Comparative analyses solid list not inhibitors. This study help guiding development novel paying attention differences between versus

参考文章(230)
Steve C. Pettit, Nijing Sheng, Radonna Tritch, Susan Erickson-Viitanen, Ronald Swanstrom, The Regulation of Sequential Processing of HIV-1 Gag by the Viral Protease Aspartic Proteinases. ,vol. 436, pp. 15- 25 ,(1998) , 10.1007/978-1-4615-5373-1_2
H. L. Turrittin, My mathematical expectations Lecture Notes in Mathematics. pp. 1- 22 ,(1973) , 10.1007/BFB0060042
David J. Huggins, Woody Sherman, Bruce Tidor, Rational approaches to improving selectivity in drug design. Journal of Medicinal Chemistry. ,vol. 55, pp. 1424- 1444 ,(2012) , 10.1021/JM2010332
Paola Gallinari, Debra Brennan, Chiara Nardi, Mirko Brunetti, Licia Tomei, Christian Steinkühler, Raffaele De Francesco, Multiple Enzymatic Activities Associated with Recombinant NS3 Protein of Hepatitis C Virus Journal of Virology. ,vol. 72, pp. 6758- 6769 ,(1998) , 10.1128/JVI.72.8.6758-6769.1998
Scott D. Seiwert, Karl Kossen, Lin Pan, Jyanwei Liu, Brad O. Buckman, Discovery and Development of the HCV NS3/4A Protease Inhibitor Danoprevir (ITMN-191/RG7227) Antiviral Drugs. pp. 257- 271 ,(2011) , 10.1002/9780470929353.CH18
Zbyszek Otwinowski, Wladek Minor, Processing of X-ray diffraction data collected in oscillation mode Methods in Enzymology. ,vol. 276, pp. 307- 326 ,(1997) , 10.1016/S0076-6879(97)76066-X
Anita Fehér, Irene T. Weber, Péter Bagossi, Péter Boross, Bhuvaneshwari Mahalingam, John M. Louis, Terry D. Copeland, Ivan Y. Torshin, Robert W. Harrison, József Tözsér, Effect of sequence polymorphism and drug resistance on two HIV‐1 Gag processing sites FEBS Journal. ,vol. 269, pp. 4114- 4120 ,(2002) , 10.1046/J.1432-1033.2002.03105.X
L Doyon, G Croteau, D Thibeault, F Poulin, L Pilote, D Lamarre, Second locus involved in human immunodeficiency virus type 1 resistance to protease inhibitors. Journal of Virology. ,vol. 70, pp. 3763- 3769 ,(1996) , 10.1128/JVI.70.6.3763-3769.1996
Maria Martell, Juan I Esteban, Josep Quer, Joan Genesca, Amy Weiner, Rafael Esteban, Jaume Guardia, Jordi Gomez, Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution. Journal of Virology. ,vol. 66, pp. 3225- 3229 ,(1992) , 10.1128/JVI.66.5.3225-3229.1992